Intravitreal administration of bevacizumab in the treatment of choroidal metastasis in a patient with erlotinib-failed pulmonary adenocarcinoma
Lung Cancer, 04/10/2012Lai CL et al.
There was no effective local treatment for saving visual acuity. The off–label use of intravitreal bevacizumab was popular in treating VEGF–mediated chorioretinal diseases worldwide. The authors here demonstrate a dramatic and durable response to intravitreal bevacizumab. Unlike the previous similar reports, the patient had failed both first– and second–line therapies.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.